Fundus Fluorescein Angiography
Eye Care
estimated about CNY 600-1200
Disclaimer: This site is a medical service platform; some page content is AI-assisted. Health-related information does not constitute medical advice. If you have any questions, please consult a healthcare professional. See full disclaimer
Description
A diagnostic imaging technique using intravenous fluorescein dye to visualize retinal and choroidal vasculature, assess blood flow, detect leaks, blockages, or abnormal vessels in the posterior segment of the eye.
Main Uses
FFA is primarily used to evaluate retinal and choroidal vascular anatomy and pathology. Key clinical applications include: diagnosing and staging diabetic retinopathy (identifying ischemia, neovascularization, macular edema); detecting choroidal neovascularization (CNV) in age-related macular degeneration; assessing retinal vascular occlusions (artery/vein); evaluating inflammatory conditions (e.g., posterior uveitis, sarcoidosis); guiding laser photocoagulation or anti-VEGF therapy planning; monitoring treatment response; and differentiating optic nerve head anomalies (e.g., papilledema vs. optic disc drusen).
Normal Range
FFA is a qualitative, dynamic imaging test—not a quantitative assay—so it has no numerical 'normal range' or standardized reference values. Normal findings include: (1) uniform, rapid filling of retinal arteries within 10–12 seconds after injection; (2) complete venous filling by 15–18 seconds; (3) no leakage, staining, or blockage of vessels; (4) intact foveal avascular zone (FAZ); (5) absence of abnormal neovascularization or hyperfluorescence. Timing and morphology are assessed visually by trained ophthalmologists using standardized angiographic phases (arm-to-retina time, arterial, capillary, venous, late phases).
Low Values - Possible Causes
Low or absent fluorescence in FFA is not due to 'low values' but reflects hypofluorescence—caused by: (1) vascular occlusion (e.g., central/branch retinal artery occlusion); (2) capillary non-perfusion (e.g., in diabetic retinopathy or retinal vein occlusion); (3) pigment or hemorrhage blocking fluorescence (e.g., subretinal hemorrhage, dense drusen, RPE hyperplasia); (4) choroidal hypoperfusion (e.g., in severe hypertension or vasospasm); (5) technical factors (e.g., under-dosing of dye, poor image acquisition, or patient motion).
High Values - Possible Causes
Hyperfluorescence in FFA—appearing as abnormally increased or persistent fluorescence—is caused by: (1) leakage from damaged retinal/choroidal vessels (e.g., diabetic macular edema, uveitis); (2) pooling of dye in fluid-filled spaces (e.g., serous retinal detachment, cystoid macular edema); (3) staining of tissues with retained dye (e.g., optic disc edema, drusen, chronic CNV); (4) abnormal neovascularization (e.g., proliferative diabetic retinopathy, wet AMD); (5) window defects due to RPE atrophy (e.g., geographic atrophy in age-related macular degeneration).
estimated about CNY 600-1200
Related Items
Dry Eye Syndrome Treatment
estimated about CNY 200-1000
Phacoemulsification with intraocular lens implantation
estimated about CNY 8000-15000
Femtosecond laser-assisted cataract surgery (FLACS)
estimated about CNY 12000-22000
YAG laser capsulotomy
estimated about CNY 800-1500
Intravitreal injection of ranibizumab
estimated about CNY 5500-6500
Intravitreal injection of conbercept
estimated about CNY 3500-4500